Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ANKRD57 antibody (AA 75-125)

ANKRD57 Reactivity: Human WB, IP Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7451628
  • Target See all ANKRD57 products
    ANKRD57 (Ankyrin Repeat Domain 57 (ANKRD57))
    Binding Specificity
    • 8
    • 8
    • 6
    • 1
    • 1
    • 1
    • 1
    AA 75-125
    Reactivity
    • 20
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 20
    Rabbit
    Clonality
    • 20
    Polyclonal
    Conjugate
    • 10
    • 2
    • 2
    • 2
    • 2
    • 2
    This ANKRD57 antibody is un-conjugated
    Application
    • 19
    • 14
    • 13
    • 2
    • 2
    Western Blotting (WB), Immunoprecipitation (IP)
    Purpose
    Rabbit anti-ANKRD57 Antibody, Affinity Purified
    Purification
    Affinity Purified
    Immunogen
    between AA 75 and 125
    Isotype
    IgG
  • Application Notes

    IP: 2 - 5 μg/mg lysate

    WB: 1:2,000 - 1:10,000

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C
    Expiry Date
    12 months
  • Target
    ANKRD57 (Ankyrin Repeat Domain 57 (ANKRD57))
    Alternative Name
    ANKRD57 (ANKRD57 Products)
    Synonyms
    ANKRD57 antibody, zgc:158337 antibody, C2orf26 antibody, 4921515A04Rik antibody, 9430099J10Rik antibody, Ankrd57 antibody, C820004L04Rik antibody, sosondowah ankyrin repeat domain family member C antibody, sosondowah ankyrin repeat domain family Cb antibody, SOWAHC antibody, Sowahc antibody, sowahcb antibody
    Background
    Background: ANKRD57 is an ankyrin-repeat-containing protein whose function has not been characterized.
    Gene ID
    65124
    NCBI Accession
    NP_075392
    UniProt
    Q53LP3
You are here: